🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
This phase I/II trial studies the side effects of fludarabine phosphate, cy...
Status
Terminated
Location
The Children's Hospital at TriStar Centennial
Start Date
2006-05-24
Trial ID
NCT00358657
This is a Phase II study following subjects proceeding with our Institution...
Status
Recruiting
Location
Masonic Cancer Center at University of Minnesota
Start Date
2023-05-01
Trial ID
NCT05805605
This phase II trial studies how well a reduced intensity conditioning regim...
Status
Terminated
Location
Ohio State University Comprehensive Cancer Center
Start Date
2020-12-22
Trial ID
NCT04205240
This is a Phase 1 clinical study designed to evaluate the safety, tolerabil...
Status
Recruiting
Location
Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital
Start Date
2025-12-01
Trial ID
NCT07297173
Treatments Being Tested
This randomized phase II trial studies how well treosulfan and fludarabine ...
Status
Unknown
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2013-11
Trial ID
NCT01894477
This study is a multicenter, single-arm, prospective phase II clinical tria...
Status
Recruiting
Location
Shanghai General Hospital
Start Date
2024-01-20
Trial ID
NCT06111612
T cell acute lymphoblastic leukemia (T-ALL)/Lymphoblastic lymphoma (LBL) is...
Status
Unknown
Location
The First Affiliated Hospital, College of Medicine, Zhejiang University
Start Date
2022-10-23
Trial ID
NCT05598593
Treatments Being Tested
The purpose of this study is to determine whether 5-Azacytidine priming bef...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2015-02-13
Trial ID
NCT02497404
Treatments Being Tested
This is a single-institution, phase II study to determine the event-free su...
Status
Completed
Location
University of Minnesota Masonic Cancer Center and Medical Center
Start Date
2016-03
Trial ID
NCT02582775